NIAID mounts nationwide HIV-TB treatment study.
Folkers
G
G
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009316:National Institutes of Health (U.S.); D015242:Ofloxacin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*; D014481:United States
D000995:Antitubercular Agents; D015242:Ofloxacin